The identification of cancer-restricted biomarkers is fundamental to the development of novel cancer therapies and diagnostic tools. The construction of comprehensive profiles to define tissue- and cancer-specific gene expression has been central to this. To this end, the exploitation of the current wealth of 'omic'-scale databases can be facilitated by automated approaches, allowing researchers to directly address specific biological questions. Here we present CancerEST, a user-friendly and intuitive web-based tool for the automated identification of candidate cancer markers/targets, for examining tissue specificity as well as for integrated expression profiling. CancerEST operates by means of constructing and meta-analyzing expressed sequ...
Breast cancer comprises several molecular subtypes with distinct clinical features and treatment res...
Transcriptome data provide a valuable resource for the study of cancer molecular mechanisms, but tec...
There are currently a few bioinformatics tools, such as dbEST, DDD and GEPIS to name a few, which ha...
The identification of cancer-restricted biomarkers is fundamental to the development of novel cancer...
The identification of cancer-restricted biomarkers is fundamental to the development of novel cancer...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
With the advent of OMICs technologies, both individual research groups and consortia have spear-head...
Cancer is one of the four major non-communicable diseases (NCD), responsible for similar to 14.6% of...
Whereas genome sequencing defines the genetic potential of an organism, transcript sequencing define...
As one of the major high-throughput gene expression databases, dbEST contains enormous amount of exp...
Whereas genome sequencing defines the genetic potential of an organism, transcript sequencing define...
We describe a method to identify candidate cancer biomarkers by analyzing numeric approximations of ...
Breast cancer comprises several molecular subtypes with distinct clinical features and treatment res...
Transcriptome data provide a valuable resource for the study of cancer molecular mechanisms, but tec...
There are currently a few bioinformatics tools, such as dbEST, DDD and GEPIS to name a few, which ha...
The identification of cancer-restricted biomarkers is fundamental to the development of novel cancer...
The identification of cancer-restricted biomarkers is fundamental to the development of novel cancer...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
With the advent of OMICs technologies, both individual research groups and consortia have spear-head...
Cancer is one of the four major non-communicable diseases (NCD), responsible for similar to 14.6% of...
Whereas genome sequencing defines the genetic potential of an organism, transcript sequencing define...
As one of the major high-throughput gene expression databases, dbEST contains enormous amount of exp...
Whereas genome sequencing defines the genetic potential of an organism, transcript sequencing define...
We describe a method to identify candidate cancer biomarkers by analyzing numeric approximations of ...
Breast cancer comprises several molecular subtypes with distinct clinical features and treatment res...
Transcriptome data provide a valuable resource for the study of cancer molecular mechanisms, but tec...
There are currently a few bioinformatics tools, such as dbEST, DDD and GEPIS to name a few, which ha...